v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Product sales, net $ 2,162,033 $ 2,232,420
Cost of products sold 598,009 584,985
Gross profit 1,564,024 1,647,435
Selling, general and administrative expenses 2,372,653 3,256,728
Research and development expenses 369,120
Depreciation and amortization expense 19,454 19,440
Total operating expenses 2,392,107 3,645,288
Loss from operations (828,083) (1,997,853)
Interest (expense) income, net (11,770) 3,267
Loss before provision for income taxes (839,853) (1,994,586)
Provision for income taxes
Net loss $ (839,853) $ (1,994,586)
Net loss per share applicable to common stockholders - basic $ (0.01) $ (0.02)
Net loss per share applicable to common stockholders - diluted $ (0.01) $ (0.02)
Weighted average shares outstanding and to be issued - basic 85,041,913 81,854,512
Weighted average shares outstanding and to be issued - diluted 85,041,913 81,854,512